Jump to main content
Jump to site search


Plasmonic MoO3-x nanoparticles incorporated in the prussian blue frameworks exhibit highly efficient dual photothermal/ photodynamic therapy

Abstract

Development of near infrared (NIR) light-responsive nanomaterials for high performance multimodal phototherapies within a single nanoplatform is still challenging in technology and biomedicine. Herein, a new phototherapeutic nano-agent based on FDA-approved prussian blue (PB) functionalized oxygen-deficient molybdenum oxide nanoparticles (MoO3–x NPs) are strategically designed and synthesized by a facile one-pot size/morphology controlled process. The as-prepared PB-MoO3–x nanocomposites (NCs) with a uniform particles size ∼90 nm and high water dispersibility, displayed strong optical absorption in the first biological window, which is induced by plasmon resonance in oxygen-deficient MoO3–x semiconductor. More importantly, PB-MoO3-x NCs not only exhibited a high photothermal conversion efficiency of ∼ 63.7 % and photostability but also offer a further approach for the generation of reactive oxygen species (ROS) upon singular NIR light irradiation which is significantly improved the therapeutic efficiency of PB agent. Furthermore, PB-MoO3–x NCs demonstrated a negligible cytotoxic effect in the dark, but an excellent therapeutic effect toward two TNBC cell lines at a low concentration (20 µg/mL) of NCs and moderate NIR laser power density. Additionally, efficient tumor ablation and metastasis inhibition in a 4T1 TNBC mouse tumor model can also be realized by synergistic photothermal/ photodynamic therapy (PTT/PDT) under a single continuous NIR wave laser. Taken together, this study paved the way to the use of a single nanosystem for multifunctional therapy.

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 Nov 2018, accepted on 31 Jan 2019 and first published on 06 Feb 2019


Article type: Paper
DOI: 10.1039/C8TB03148G
Citation: J. Mater. Chem. B, 2019, Accepted Manuscript

  •   Request permissions

    Plasmonic MoO3-x nanoparticles incorporated in the prussian blue frameworks exhibit highly efficient dual photothermal/ photodynamic therapy

    A. H. Odda, Y. Xu, J. Lin, G. Wang, N. Ullah, A. Zeb, K. Liang, W. longping and A. Xu, J. Mater. Chem. B, 2019, Accepted Manuscript , DOI: 10.1039/C8TB03148G

Search articles by author

Spotlight

Advertisements